Dying in times of the coronavirus: An online survey among healthcare professionals about end-of-life care for patients dying with and without COVID-19 (the CO-LIVE study).

COVID-19 end of life palliative care quality of care quality of dying

Journal

Palliative medicine
ISSN: 1477-030X
Titre abrégé: Palliat Med
Pays: England
ID NLM: 8704926

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 8 4 2021
medline: 15 5 2021
entrez: 7 4 2021
Statut: ppublish

Résumé

During the COVID-19 outbreak restricting measures may have affected the provision of good end-of-life care for patients with and without COVID-19. To describe characteristics of patients who died and the care they received, and to examine how patient characteristics, setting and visiting restrictions are related to provided care and evaluation of the dying process. An open observational online survey among healthcare professionals about their experience of end-of-life care that was provided to a patient with or without COVID-19 who died between March and July 2020. Healthcare professionals (nurses, physicians and others) in the Netherlands from all settings: home ( Of patients reported on, 56% had COVID-19. Among these patients, 358 (84.4%) also had a serious chronic illness. Having COVID-19 was negatively, and having a serious chronic illness was positively associated with healthcare staff's favourable appreciation of end-of-life care. Often there had been visiting restrictions in the last 2 days of life (75.8%). This was negatively associated with appreciation of care at the end of life and the dying process. Finally, care at the end of life was less favourably appreciated in hospitals and especially nursing homes, and more favourably in home settings and especially hospices. Our study suggests that end-of-life care during the COVID-19 pandemic may be further optimised, especially in nursing homes and hospitals. Allowing at least some level of visits of relatives seems a key component.

Sections du résumé

BACKGROUND
During the COVID-19 outbreak restricting measures may have affected the provision of good end-of-life care for patients with and without COVID-19.
AIM
To describe characteristics of patients who died and the care they received, and to examine how patient characteristics, setting and visiting restrictions are related to provided care and evaluation of the dying process.
DESIGN
An open observational online survey among healthcare professionals about their experience of end-of-life care that was provided to a patient with or without COVID-19 who died between March and July 2020.
SETTING/PARTICIPANTS
Healthcare professionals (nurses, physicians and others) in the Netherlands from all settings: home (
RESULTS
Of patients reported on, 56% had COVID-19. Among these patients, 358 (84.4%) also had a serious chronic illness. Having COVID-19 was negatively, and having a serious chronic illness was positively associated with healthcare staff's favourable appreciation of end-of-life care. Often there had been visiting restrictions in the last 2 days of life (75.8%). This was negatively associated with appreciation of care at the end of life and the dying process. Finally, care at the end of life was less favourably appreciated in hospitals and especially nursing homes, and more favourably in home settings and especially hospices.
CONCLUSIONS
Our study suggests that end-of-life care during the COVID-19 pandemic may be further optimised, especially in nursing homes and hospitals. Allowing at least some level of visits of relatives seems a key component.

Identifiants

pubmed: 33825567
doi: 10.1177/02692163211003778
pmc: PMC8114455
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

830-842

Références

Br J Gen Pract. 2011 Jun;61(587):e371-8
pubmed: 21801517
Int J Nurs Stud. 2012 Aug;49(8):931-40
pubmed: 22425065
J Pain Symptom Manage. 2020 Jul;60(1):e77-e81
pubmed: 32325167
Palliat Med. 2020 Oct;34(9):1235-1240
pubmed: 32588748
Palliat Med. 2020 Oct;34(9):1249-1255
pubmed: 32736493
Qual Manag Health Care. 2017 Oct/Dec;26(4):210-217
pubmed: 28991817
Eur J Public Health. 2015 Aug;25(4):569-75
pubmed: 25829502
Palliat Med. 2020 Oct;34(9):1256-1262
pubmed: 32794435
PLoS One. 2020 Nov 17;15(11):e0241955
pubmed: 33201896
Palliat Med. 2020 Oct;34(9):1193-1201
pubmed: 32706299
BMJ Support Palliat Care. 2014 Jun;4(2):167-174
pubmed: 24681559
Palliat Med. 2004 Jan;18(1):12-8
pubmed: 14982202
J Palliat Med. 2021 Apr;24(4):514-519
pubmed: 32746685
J Pain Symptom Manage. 2020 Oct;60(4):e2-e13
pubmed: 32721500
Int Psychogeriatr. 2020 Nov;32(11):1345-1352
pubmed: 32389141
Am J Hosp Palliat Care. 2020 Nov;37(11):988-991
pubmed: 32705889
Int J Nurs Stud. 2016 Feb;54:122-31
pubmed: 25794947

Auteurs

Bregje D Onwuteaka-Philipsen (BD)

Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Expertise Center for Palliative Care, Amsterdam UMC, VU University, Amsterdam, The Netherlands.

H Roeline W Pasman (HRW)

Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Expertise Center for Palliative Care, Amsterdam UMC, VU University, Amsterdam, The Netherlands.

Ida J Korfage (IJ)

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Erica Witkamp (E)

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Research Center Innovations in Care, Rotterdam University of Applied Sciences, Rotterdam, The Netherlands.

Masha Zee (M)

Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Expertise Center for Palliative Care, Amsterdam UMC, VU University, Amsterdam, The Netherlands.

Liza Gg van Lent (LG)

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Anne Goossensen (A)

University of Humanistic Studies, Utrecht, The Netherlands.

Agnes van der Heide (A)

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH